Inovio announces proposed public offering of common stock

Plymouth meeting, pa., jan. 20, 2021 /prnewswire/ -- inovio pharmaceuticals, inc. (nasdaq: ino), a biotechnology company focused on bringing to market precisely designed dna medicines to treat and protect people from infectious diseases, including covid-19, cancer and hpv-associated...
INO Ratings Summary
INO Quant Ranking